Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 2
2009 2
2010 1
2011 2
2012 2
2013 5
2014 2
2015 3
2016 2
2017 3
2018 3
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.
Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, Huang DC, Hymowitz SG, Jin S, Khaw SL, Kovar PJ, Lam LT, Lee J, Maecker HL, Marsh KC, Mason KD, Mitten MJ, Nimmer PM, Oleksijew A, Park CH, Park CM, Phillips DC, Roberts AW, Sampath D, Seymour JF, Smith ML, Sullivan GM, Tahir SK, Tse C, Wendt MD, Xiao Y, Xue JC, Zhang H, Humerickhouse RA, Rosenberg SH, Elmore SW. Souers AJ, et al. Among authors: mason kd. Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6. Nat Med. 2013. PMID: 23291630
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Zelenetz AD, Salles G, Mason KD, Casulo C, Le Gouill S, Sehn LH, Tilly H, Cartron G, Chamuleau MED, Goy A, Tam CS, Lugtenburg PJ, Petrich AM, Sinha A, Samineni D, Herter S, Ingalla E, Szafer-Glusman E, Klein C, Sampath D, Kornacker M, Mobasher M, Morschhauser F. Zelenetz AD, et al. Among authors: mason kd. Blood. 2019 May 2;133(18):1964-1976. doi: 10.1182/blood-2018-11-880526. Epub 2019 Mar 8. Blood. 2019. PMID: 30850381 Free PMC article. Clinical Trial.
Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.
Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O'Reilly L, Mason K, Gross O, Ma S, Guarda G, Anderton H, Castillo R, Häcker G, Silke J, Tschopp J. Vince JE, et al. Among authors: mason k. Immunity. 2012 Feb 24;36(2):215-27. doi: 10.1016/j.immuni.2012.01.012. Immunity. 2012. PMID: 22365665 Free article.
Programmed anuclear cell death delimits platelet life span.
Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, Huang DC, Kile BT. Mason KD, et al. Cell. 2007 Mar 23;128(6):1173-86. doi: 10.1016/j.cell.2007.01.037. Cell. 2007. PMID: 17382885 Free article.
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Bromberg JEC, Issa S, Bakunina K, Minnema MC, Seute T, Durian M, Cull G, Schouten HC, Stevens WBC, Zijlstra JM, Baars JW, Nijland M, Mason KD, Beeker A, van den Bent MJ, Beijert M, Gonzales M, de Jong D, Doorduijn JK. Bromberg JEC, et al. Among authors: mason kd. Lancet Oncol. 2019 Feb;20(2):216-228. doi: 10.1016/S1470-2045(18)30747-2. Epub 2019 Jan 7. Lancet Oncol. 2019. PMID: 30630772 Clinical Trial.
Why did we fail? Challenges recruiting parents with cancer into a psycho-educational support program.
Stafford L, Sinclair M, Newman L, Rauch P, Barton M, Gilham L, Cannell J, Mason K, Joubert L, Hocking A, Little R. Stafford L, et al. Among authors: mason k. Psychooncology. 2019 Dec;28(12):2425-2428. doi: 10.1002/pon.5226. Epub 2019 Oct 31. Psychooncology. 2019. PMID: 31518028 No abstract available.
Comparison of gene expression and flow cytometry for immune profiling in chronic lymphocytic leukaemia.
Sharpe C, Davis J, Mason K, Tam C, Ritchie D, Koldej R. Sharpe C, et al. Among authors: mason k. J Immunol Methods. 2018 Dec;463:97-104. doi: 10.1016/j.jim.2018.09.013. Epub 2018 Sep 26. J Immunol Methods. 2018. PMID: 30267664
Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.
Au AE, Lebois M, Sim SA, Cannon P, Corbin J, Gangatirkar P, Hyland CD, Moujalled D, Rutgersson A, Yassinson F, Kile BT, Mason KD, Ng AP, Alexander WS, Josefsson EC. Au AE, et al. Among authors: mason kd. Sci Rep. 2017 Nov 2;7(1):14953. doi: 10.1038/s41598-017-15023-2. Sci Rep. 2017. PMID: 29097774 Free PMC article.
The Importance of Using Public Health Impact Criteria to Develop Environmental Health Indicators: The Example of the Indoor Environment in New Zealand.
Mason K, Lindberg K, Read D, Borman B. Mason K, et al. Int J Environ Res Public Health. 2018 Aug 20;15(8):1786. doi: 10.3390/ijerph15081786. Int J Environ Res Public Health. 2018. PMID: 30127284 Free PMC article.
35 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback